Skip to main navigation Skip to search Skip to main content

The antioxidant effects of melatonin in surgical brain injury in rats

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

Background Surgical brain injury (SBI) to normal brain tissue can occur as inevitable sequelae of neurosurgical operations. SBI can contribute to post-operative complications such as brain edema following blood-brain barrier (BBB) disruption leading to neurological deficits. Melatonin is a commonly used drug with known antioxidant properties and neuroprotective effects in experimental animal studies (Chen et al., J Pineal Res 41:175-182, 2006; Chen et al., J Pineal Res 40(3):242-250, 2006; Cheung, J Pineal Res 34:153-160, 2003; Lee et al., J Pineal Res 42(3):297-309, 2007; Reiter et al., Exp Biol Med (Maywood) 230(2):104-117, 2005) Methods We tested different concentrations of melatonin (5 mg/kg, 15 mg/kg and 150 mg/kg) administered 1 hour before surgery for neuroprotection against SBI using a rodent model. Post-operative assessment included brain water content (brain edema), lipid peroxidation assays (oxidative stress), and neurological assessment. Findings The results showed a trend in decreasing brain edema with lower doses of melatonin (5 mg/kg and 15 mg/ kg), however, high concentration of melatonin (150 mg/kg) significantly increased brain edema compared to all other groups. This deleterious effect of high-dose melatonin was also observed in lipid-peroxidation assay wherein lower-dose melatonin (15 mg/kg) attenuated oxidative stress, but high-dose melatonin (150 mg/kg) increased oxidative stress as compared to vehicle-treated group. Furthermore, high-dose melatonin also worsened neurological outcomes compared to other groups whereas; the low-dose melatonin group (15 mg/kg) showed some improved neurological parameters. Conclusions The study suggests that low-dose melatonin may provide neuroprotective effects against SBI. Further studies are needed to confirm this. More importantly, the findings of the study stress the need to carefully reassess safety issues with high doses of melatonin, which is considered to be a practically non-toxic drug. © 2008 Springer-Verlag/Wien.
Original languageAmerican English
Title of host publicationIntracranial Pressure and Brain Monitoring XIII
Subtitle of host publicationMechanisms and Treatment
PublisherSpringer Vienna
Pages367-371
Number of pages5
ISBN (Electronic)978-3-211-85578-2
ISBN (Print)9783211855775, 978-3-211-99942-4
DOIs
StatePublished - Jan 9 2009

Publication series

NameActa Neurochirurgica, Supplementum
Number102
ISSN (Print)0065-1419
ISSN (Electronic)2197-8395

ASJC Scopus Subject Areas

  • Surgery
  • Clinical Neurology

Keywords

  • Brain-edema
  • Melatonin
  • Neuroprotection
  • Surgical brain-injury
  • Melatonin/therapeutic use
  • Neuroprotective Agents/therapeutic use
  • Rats
  • Brain Injuries/complications
  • Dose-Response Relationship, Drug
  • Brain Edema/etiology
  • Lipid Peroxidation/drug effects
  • Animals
  • Analysis of Variance
  • Neurologic Examination/methods
  • Disease Models, Animal

Disciplines

  • Anesthesiology
  • Medicine and Health Sciences
  • Endocrinology, Diabetes, and Metabolism

Cite this